Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

1RGB

Phospholipase A2 from Vipera ammodytes meridionalis

Summary for 1RGB
Entry DOI10.2210/pdb1rgb/pdb
DescriptorPhospholipase A2, (9E)-OCTADEC-9-ENAMIDE (2 entities in total)
Functional Keywordsphospholipase a2, neurotoxin, elaidoylamide, hydrolase
Biological sourceVipera ammodytes meridionalis
Total number of polymer chains4
Total formula weight55950.24
Authors
Georgieva, D.N. (deposition date: 2003-11-12, release date: 2005-01-18, Last modification date: 2024-10-30)
Primary citationGeorgieva, D.N.,Rypniewski, W.,Gabdoulkhakov, A.,Genov, N.,Betzel, C.
Asp49 phospholipase A(2)-elaidoylamide complex: a new mode of inhibition.
Biochem.Biophys.Res.Commun., 319:1314-1321, 2004
Cited by
PubMed Abstract: The inhibition of phospholipase A(2)s (PLA(2)s) is of pharmacological and therapeutic interest because these enzymes are involved in several inflammatory diseases. Elaidoylamide is a powerful inhibitor of a neurotoxic PLA(2) from the Vipera ammodytes meridionalis venom. The X-ray structure of the enzyme-inhibitor complex reveals a new mode of Asp49 PLA(2) inhibition by a fatty acid hydrocarbon chain. The structure contains two identical homodimers in the asymmetric unit. In each dimer one subunit is rotated by 180 degrees with respect to the other and the two molecules are oriented head-to-tail. One molecule of elaidoylamide is bound simultaneously to the substrate binding sites of two associated neurotoxic phospholipase A(2) molecules. The inhibitor binds symmetrically to the hydrophobic channels of the two monomers. The structure can be used to design anti-inflammatory drugs.
PubMed: 15194511
DOI: 10.1016/j.bbrc.2004.05.106
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.3 Å)
Structure validation

227344

건을2024-11-13부터공개중

PDB statisticsPDBj update infoContact PDBjnumon